BackGSK plc Overview

GSK plc Intangible Assets

Latest intangible assets for GLAXF: $25B.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$25.34B

Peer trimmed avg / median

Loading

GSK plc Intangible Assets History

Loading

GSK plc vs. peers: Intangible Assets Comparison

Loading

GSK plc Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GSK plc (GLAXF) FAQ

As of the most recent data (September 2026), GLAXF shows a intangible assets of $25B. Scroll down for historical charts and peer comparison views.

Tracking GLAXF's intangible assets over time shows whether GSK plc is scaling, shrinking, or reshaping that part of the business. The current reading is $25B Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has GSK plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $25B) with ownership activity and broader fundamentals.

GSK plc's intangible assets is $25B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.